ALKERMES reported $290.9M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US USD 37.16B 1.46B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
Horizon Pharma HZNP:US USD 2.55B 1.85M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Otsuka Holdings 4578:JP JPY 154.99B 2.22B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Revance Therapeutics RVNC:US USD 378.89M 506K
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M